Malignant Hematology
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
Treatment of R/R CLL: Efficacy and Safety of Ibrutinib, PFS Benefit With VenR, LOXO-305 Is Highly Effective in Heavily Pretreated B-cell Malignancies & CAR T-cell Therapy is a Promising Alternative
FEATURING
Nitin Jain
- 26 views
- March 4, 2020
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
Does Rituximab Treated Patient Need Immunization? Case of 41 y/o Man With R/R Immune Thrombocytopenic Purpura: Complications of Rituximab & Infection Prevention Strategies
FEATURING
Luis Malpica Castillo
- 48 views
- March 4, 2020